|Last Price||Today's Change||52-Week Range||Trading Volume|
|17.24||0.07 (+0.41%)||15.77 - 20.24||17.1 thousand (Above Avg)|
Market data as of 3:31PM 03/07/14. Quotes are delayed by at least 15 min.
Daiichi Sankyo Submits SAVAYSA™ (edoxaban) Tablets New Drug Application to the U.S. FDA for Once-Daily Use for Stroke Risk Reduction in Atrial Fibrillation and for the Treatment and Prevention of Recurrence of Venous Thromboembolism
01/08/2014 12:29 PM ET
Daiichi Sankyo Submits Edoxaban Marketing Authorization Application to the EMA for Once-Daily Use for Stroke Prevention in Atrial Fibrillation and for the Treatment and Prevention of Recurrence of Venous Thromboembolism
01/07/2014 11:09 AM ET